Xtalks Announces its Life Science Webinar Calendar for May 2026
Upcoming free, educational webinars from Xtalks will feature topics in biomarkers, clinical trials, drug discovery & development, healthcare, medical device and pharma manufacturing & supply chain.
Visit www.xtalks.com to see our upcoming webinars:
BIOMARKERS
CLINICAL TRIALS
DRUG DISCOVERY & DEVELOPMENT
HEALTHCARE
MEDICAL DEVICE
PHARMA MANUFACTURING & SUPPLY CHAIN
ABOUT XTALKS
Xtalks — The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.
Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what's next.
To learn more about Xtalks, visit www.xtalks.com
For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us/
Contact:
Tel: +1 (416) 977-6555 x272
Email: [email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/xtalks-announces-its-life-science-webinar-calendar-for-may-2026-302760141.html
SOURCE Xtalks
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PETFINDER MARKS 30TH ANNIVERSARY WITH RESCUE FLIGHTS FOR SHELTER PETS AND AN INVITATION FOR PEOPLE TO HELP FILL MILLIONS OF BOWLS
- Jack Henry & Associates, Inc. Reports Fourth Quarter and Full Year Fiscal 2026 Results
- EQB Inc. releases an abridged supplemental financial information package for third quarter 2026 results
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share